Abstract
The occurrence of heteroplasmy and mixtures is technically challenging for the analysis of mitochondrial DNA. More than that, observed mutations need to be carefully interpreted in the light of the phylogeny as mitochondrial DNA is a uniparental marker reflecting human evolution. Earlier attempts to explain the role of mtDNA in cancerous tissues led to substantial confusion in medical genetics mainly due to the presentation of low sequence data quality and misinterpretation of mutations representing a particular haplogroup background rather than being cancer-specific. The focus of this study is to characterize the extent and level of mutations in breast cancer samples obtained by tissue microdissection by application of an evaluated full mtDNA genome sequencing protocol. We amplified and sequenced the complete mitochondrial genomes of microdissected breast cancer cells of 15 patients and compared the results to those obtained from paired non-cancerous breast tissue derived from the same patients. We observed differences in the heteroplasmic states of substitutions between cancerous and normal cells, one of which was affecting a position that has been previously reported in lung cancer and another one that has been identified in 16 epithelial ovarian tumors, possibly indicating functional relevance. In the coding region, we found full transitions in two cancerous mitochondrial genomes and 12 heteroplasmic substitutions as compared to the non-cancerous breast cells. We identified somatic mutations over the entire mtDNA of human breast cancer cells potentially impairing the mitochondrial OXPHOS system.
Similar content being viewed by others
Abbreviations
- mtDNA:
-
Mitochondrial DNA
- LCM:
-
Laser capture microdissection
- ND:
-
NADH dehydrogenase
- CO:
-
Cytochrome oxidase
- Cytb:
-
Cytochrome b
- OXPHOS:
-
Oxidative phosphorylation
References
Warburg O (1956) On the origin of cancer cells. Science 123:309–314
Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases aging and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359–407
Brandon M, Baldi P, Wallace DC (2006) Mitochondrial mutations in cancer. Oncogene 25:4647–4662
Bianchi NO, Bianchi MS, Richard SM (2001) Mitochondrial genome instability in human cancers. Mutat Res 488:9–23
Santos C, Martínez M, Lima M, Hao YJ, Simoes N, Montiel R (2008) Mitochondrial DNA mutations in cancer: a review. Curr Top Med Chem 8:1351–1366
Salas A, Yao YG, Macaulay V, Vega A, Carracedo A, Bandelt HJ (2005) A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2:e296
Chen D, Zhan H (2009) Study on the mutations in the D-loop region of mitochondrial DNA in cervical carcinoma. J Cancer Res Clin Oncol 135:291–295
HeY, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, Diaz Jr LA, Kinzler KW, Vogelstein B, Papadopoulos N (2010) Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature. doi:10.1038/nature08802
van Oven M, Kayser M (2008) Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat 1039:e386–e394
Wang CY, Wang HW, Yao YG, Kong QP, Zhang YP (2007) Somatic mutations of mitochondrial genome in early stage breast cancer. Int J Cancer 121:1253–1256
Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-Jimenez P, Thilly WG (2001) High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 28:147–150
Maximo V, Lima J, Soares P, Sobrinho-Simoes M (2009) Mitochondria and cancer. Virchows Arch 454:481–495
Beerenwinkel N, Antal T, Dingli D, Traulsen A, Kinzler KW, Velculescu VE, Vogelstein B, Nowak MA (2007) Genetic progression and the waiting time to cancer. PLoS Comput Biol 3:e225
Bandelt HJ, Salas A, Bravi CM (2006) What is a ‘novel’ mtDNA mutation—and does ‘novelty’ really matter? J Hum Genet 51:1073–1082
Fendt L, Zimmermann B, Daniaux M, Parson W (2009) Sequencing strategy for the whole mitochondrial genome resulting in high quality sequences. BMC Genomics 10:139
Niederstätter H, Köchl S, Grubwieser P, Pavlic M, Steinlechner M, Parson W (2007) A modular real-time PCR concept for determining the quantity and quality of human nuclear and mitochondrial DNA. Forensic Sci Int Genet 1:29–34
Parson W, Bandelt HJ (2007) Extended guidelines of mtDNA typing of population data in forensic science. Forensic Sci Int Genet 1:13–19
Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG (1981) Sequence and organization of the human mitochondrial genome. Nature 290:457–465
Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23:147
Carracedo A, Bär W, Lincoln P, Mayr W, Morling N, Olaisen B, Schneider P, Budowle B, Brinkmann B, Gill P, Holland M, Tully G, Wilson M (2000) DNA Commission of the International Society for Forensic Genetics: guidelines for mitochondrial DNA typing. Forensic Sci Int 110:79–85
Tully G, Bär W, Brinkmann B, Carracedo A, Gill P, Morling N, Parson W, Schneider P (2001) Considerations by the European DNA profiling (EDNAP) group on the working practices nomenclature and interpretation of mitochondrial DNA profiles. Forensic Sci Int 124:83–91
Bandelt HJ, Parson W (2007) Consistent treatment of length variants in the human mtDNA control region: a reappraisal. Int J Legal Med 122:11–21
Irwin JA, Saunier JL, Niederstätter H, Strouss KM, Sturk KA, Diegoli TM, Brandstätter A, Parson W, Parsons TJ (2009) Investigation of heteroplasmy in the human mitochondrial DNA control region: a synthesis of observations from more than 5000 global population samples. J Mol Evol 68:516–527
Malyarchuk BA, Derenko MV (1999) Molecular instability of the mitochondrial haplogroup T sequences at nucleotide positions 16292 and 16296. Ann Hum Genet 63:489–497
Bandelt HJ, Kong QP, Richards M, Macaulay V (2006) Estimation of mutation rates and coalescence times: some caveats. In: Bandelt HJ, Macaulay V, Richards M (eds) Human mitochondrial DNA and the evolution of Homo sapiens. Springer, Berlin, pp 47–90
Bandelt HJ, Quintana-Murci L, Salas A, Macaulay V (2002) The fingerprint of phantom mutations in mitochondrial DNA data. Am J Hum Genet 71:1150–1160
Vernesi C, Fuselli S, Castrí L, Bertorelle G, Barbujani G (2002) Mitochondrial diversity in linguistic isolates of the Alps: a reappraisal. Hum Biol 74:725–730
Achilli A, Rengo C, Magri C, Battaglia V, Olivieri A, Scozzari R, Cruciani F, Zeviani M, Briem E, Carelli V, Moral P, Dugoujon JM, Roostalu U, Loogväli EL, Kivisild T, Bandelt HJ, Richards M, Villems R, Santachiara-Benerecetti AS, Semino O, Torroni A (2004) The molecular dissection of mtDNA haplogroup H confirms that the Franco-Cantabrian glacial refuge was a major source for the European gene pool. Am J Hum Genet 75:910–918
Kassauei K, Habbe N, Mullendore ME, Karikari CA, Maitra A, Feldmann G (2006) Mitochondrial DNA mutations in pancreatic cancer. Int J Gastrointest Cancer 37:57–64
Zhu W, Qin W, Bradley P, Wessel A, Puckett CL, Sauter ER (2005) Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis 26:145–152
Rosson D, Keshgegian AA (2004) Frequent mutations in the mitochondrial control region DNA in breast tissue. Cancer Lett 215:89–94
Tan DJ, Bai RK, Wong LJ (2002) Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 62:972–976
Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, Nicol T, Gabrielson E, Cuomo C, Cohen D, Pandit S, Spencer M, Rabitti C, Fazio VM, Sidransky D (2001) Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 61:7623–7626
Singh KK, Ayyasamy V, Owens KM, Koul MS, Vujcic M (2009) Mutations in mitochondrial DNA polymerase-gamma promote breast tumorigenesis. J Hum Genet 54:516–524
Tzen CY, Mau BL, Wu TY (2007) ND4 mutation in transitional cell carcinoma: does mitochondrial mutation occur before tumorigenesis? Mitochondrion 7:273–278
Park JS, Sharma LK, Li H, Xiang R, Holstein D, Wu J, Lechleiter J, Naylor SL, Deng JJ, Lu J, Bai Y (2009) A heteroplasmic not homoplasmic mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum Mol Genet 18:1578–1589
Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, Marshall FF, Wallace DC (2005) mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 102:719–724
Aikhionbare FO, Mehrabi S, Kumaresan K, Zavareh M, Olatinwo M, Odunsi K, Partridge E (2007) Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages. J Carcinog 6:1
Lorenc A, Bryk J, Golik P, Kupryjanczyk J, Ostrowski J, Pronicki M, Semczuk A, Szolkowska M, Bartnik E (2003) Homoplasmic MELAS A3243G mtDNA mutation in a colon cancer sample. Mitochondrion 3:119–124
Vega A, Salas A, Gamborino E, Sobrido MJ, Macaulay V, Carracedo A (2004) mtDNA mutations in tumors of the central nervous system reflect the neutral evolution of mtDNA in populations. Oncogene 23:1314–1320
Rothfuss O, Gasser T, Patenge N (2009) Analysis of differential DNA damage in the mitochondrial genome employing a semi-long run real-time PCR approach. Nucleic Acids Res. doi: 10.1093/nar/gkp1082
Gasparre G, Porcelli AM, Bonora E, Pennisi LF, Toller M, Iommarini L, Ghelli A, Moretti M, Betts CM, Martinelli GN, Ceroni AR, Curcio F, Carelli V, Rugolo M, Tallini G, Romeo G (2007) Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors. Proc Natl Acad Sci USA 104:9001–9006
Gasparre G, Hervouet E, de LE, Demont J, Pennisi LF, Colombel M, Mege-Lechevallier F, Scoazec JY, Bonora E, Smeets R, Smeitink J, Lazar V, Lespinasse J, Giraud S, Godinot C, Romeo G, Simonnet H (2008) Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma. Hum Mol Genet 17:986–995
Zhidkov I, Livneh EA, Rubin E, Mishmar D (2009) mtDNA mutation pattern in tumors and human evolution are shaped by similar selective constraints. Genome Res 19:576–580
Acknowledgments
AR and WP were supported by the FWF Austrian Science Fund Translational Research Programme (L397). We are grateful to o.Univ.-Prof. Dr. Raimund Margreiter (Department of Operative Medicine, Innsbruck Medical University) for supporting the study.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fendt, L., Niederstätter, H., Huber, G. et al. Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection. Breast Cancer Res Treat 128, 327–336 (2011). https://doi.org/10.1007/s10549-010-1092-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-010-1092-8